We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HMS Holdings (HMSY) Q2 Earnings and Revenues Top Estimates
Read MoreHide Full Article
HMS Holdings Corp. reported adjusted earnings of 34 cents per share in second-quarter 2019, which surpassed the Zacks Consensus Estimate of 26 cents by 30.8%. The bottom line also surged 36% from the year-ago quarter.
Revenues totaled $168.2 million, which beat the Zacks Consensus Estimate by 5.5%. Moreover, the top line improved 14.6% on a year-over-year basis.
Q2 Segmental Analysis by Product
Analytical Services
Revenues at this segment were $63.1 million in the second quarter, up 37.2% year over year.
Within Analytical Services, PI revenues (excluding Medicare RAC) amounted to $38.6 million, up 23.7% year over year.
PHM revenues totaled $14 million in the quarter under review, down 5.4% on a year-over-year basis.
COB
Revenues at the COB segment grossed $105.1 million in the second quarter, up 4.3% year over year.
HMS Holdings Corp Price, Consensus and EPS Surprise
Total cost of services in the reported quarter was $99.6 million, down 1.4% year over year.
Gross profit came in at $68.6 million, which surged 49.9% from the prior-year quarter figure. Gross margin was 40.8% of net revenues, up 960 bps year over year.
Selling, general and administrative expenses totaled $28 million, up 5.7% year over year. Operating income in the second quarter was $40.5 million, against operating loss of $0.8 million in the year-ago quarter.
Financial Update
Cash and cash equivalents amounted to $268.7 million, up 50.1% from the year-end 2018.
Net cash provided by operating activities for the six months ended Jun 30, 2019, came in at $78.1 million, compared with $23.7 million from the year-ago quarter.
Guidance Raised
For 2019, the company now anticipates revenues between $650 million and $660 million (up from the previously guided range of $640-$650 million). This depicts year-over-year growth in the band of 8.6-10.3%. The mid-point of $655 million is above the Zacks Consensus Estimate of $646.9 million.
Net income is expected in the band of $85-$90 million (up from the prior band of $64-$70 million), indicating growth in the range of 54.5-63.6% year over year.
Adjusted EBITDA is expected in the range of $185-$190 million (up from the previously guided range of $170-$175 million), suggesting improvement of 14-17%.
Summing Up
HMS Holdings ended the second quarter of 2019 on a solid note, beating the Zacks Consensus Estimate on both counts. The stock continues to benefit from Analytical Services and COB units. Additionally, gross margin expansion is a positive. Raised 2019 outlook also buoys optimism for the stock.
However, cut throat competition in the U.S. medical cost containment space remains a concern.
Zacks Rank
Currently, HMS Holdings carries a Zacks Rank #3 (Hold).
Earnings of Other MedTech Majors at a Glance
Some better-ranked stocks which reported solid results this earning season are Stryker Corporation (SYK - Free Report) , Baxter International Inc. (BAX - Free Report) and Intuitive Surgical, Inc. (ISRG - Free Report) .
Stryker delivered second-quarter 2019 adjusted earnings per share of $1.98, beating the Zacks Consensus Estimate by 2.6%. Revenues of $3.65 billion surpassed the Zacks Consensus Estimate by 1.4%. The company carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Baxter delivered second-quarter 2019 adjusted earnings of 89 cents per share, which surpassed the Zacks Consensus Estimate of 81 cents by 9.9%. Revenues of $2.84 billion outpaced the Zacks Consensus Estimate of $2.79 billion by 1.9%. The company carries a Zacks Rank #2.
Intuitive Surgical reported second-quarter 2019 adjusted earnings per share of $3.25, which beat the Zacks Consensus Estimate of $2.85. Revenues were $1.1 billion, surpassing the Zacks Consensus Estimate of $1.03 billion. The company sports a Zacks Rank #1.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Image: Bigstock
HMS Holdings (HMSY) Q2 Earnings and Revenues Top Estimates
HMS Holdings Corp. reported adjusted earnings of 34 cents per share in second-quarter 2019, which surpassed the Zacks Consensus Estimate of 26 cents by 30.8%. The bottom line also surged 36% from the year-ago quarter.
Revenues totaled $168.2 million, which beat the Zacks Consensus Estimate by 5.5%. Moreover, the top line improved 14.6% on a year-over-year basis.
Q2 Segmental Analysis by Product
Analytical Services
Revenues at this segment were $63.1 million in the second quarter, up 37.2% year over year.
Within Analytical Services, PI revenues (excluding Medicare RAC) amounted to $38.6 million, up 23.7% year over year.
PHM revenues totaled $14 million in the quarter under review, down 5.4% on a year-over-year basis.
COB
Revenues at the COB segment grossed $105.1 million in the second quarter, up 4.3% year over year.
HMS Holdings Corp Price, Consensus and EPS Surprise
HMS Holdings Corp price-consensus-eps-surprise-chart | HMS Holdings Corp Quote
Margin Analysis
Total cost of services in the reported quarter was $99.6 million, down 1.4% year over year.
Gross profit came in at $68.6 million, which surged 49.9% from the prior-year quarter figure. Gross margin was 40.8% of net revenues, up 960 bps year over year.
Selling, general and administrative expenses totaled $28 million, up 5.7% year over year. Operating income in the second quarter was $40.5 million, against operating loss of $0.8 million in the year-ago quarter.
Financial Update
Cash and cash equivalents amounted to $268.7 million, up 50.1% from the year-end 2018.
Net cash provided by operating activities for the six months ended Jun 30, 2019, came in at $78.1 million, compared with $23.7 million from the year-ago quarter.
Guidance Raised
For 2019, the company now anticipates revenues between $650 million and $660 million (up from the previously guided range of $640-$650 million). This depicts year-over-year growth in the band of 8.6-10.3%. The mid-point of $655 million is above the Zacks Consensus Estimate of $646.9 million.
Net income is expected in the band of $85-$90 million (up from the prior band of $64-$70 million), indicating growth in the range of 54.5-63.6% year over year.
Adjusted EBITDA is expected in the range of $185-$190 million (up from the previously guided range of $170-$175 million), suggesting improvement of 14-17%.
Summing Up
HMS Holdings ended the second quarter of 2019 on a solid note, beating the Zacks Consensus Estimate on both counts. The stock continues to benefit from Analytical Services and COB units. Additionally, gross margin expansion is a positive. Raised 2019 outlook also buoys optimism for the stock.
However, cut throat competition in the U.S. medical cost containment space remains a concern.
Zacks Rank
Currently, HMS Holdings carries a Zacks Rank #3 (Hold).
Earnings of Other MedTech Majors at a Glance
Some better-ranked stocks which reported solid results this earning season are Stryker Corporation (SYK - Free Report) , Baxter International Inc. (BAX - Free Report) and Intuitive Surgical, Inc. (ISRG - Free Report) .
Stryker delivered second-quarter 2019 adjusted earnings per share of $1.98, beating the Zacks Consensus Estimate by 2.6%. Revenues of $3.65 billion surpassed the Zacks Consensus Estimate by 1.4%. The company carries a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Baxter delivered second-quarter 2019 adjusted earnings of 89 cents per share, which surpassed the Zacks Consensus Estimate of 81 cents by 9.9%. Revenues of $2.84 billion outpaced the Zacks Consensus Estimate of $2.79 billion by 1.9%. The company carries a Zacks Rank #2.
Intuitive Surgical reported second-quarter 2019 adjusted earnings per share of $3.25, which beat the Zacks Consensus Estimate of $2.85. Revenues were $1.1 billion, surpassing the Zacks Consensus Estimate of $1.03 billion. The company sports a Zacks Rank #1.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>